Concepedia

Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial

Xavier Roblin, Nicolas Williet, Gilles Boschetti, Jean–Marc Phelip, Émilie Del Tedesco, Anne‐Emmanuelle Berger, Philippe Vedrines, Gérard Duru, Laurent Peyrin‐Biroulet, Stéphane Nancey,

Gut · 2020 · 132 citations · 22 references

DOI

Abstract

03580876.

References

22

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

Jean‐Frédéric Colombel, William J. Sandborn, Walter Reinisch et al. · New England Journal of Medicine · 2010 · 3.1K citations · Full text

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

Nicholas A. Kennedy, Graham Heap, Harry Green et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 655 citations · Full text

, , +9

Withdrawal of Immunosuppression in Crohn's Disease Treated With Scheduled Infliximab Maintenance: A Randomized Trial

Gert Van Assche, Charlotte Magdelaine–Beuzelin, Geert D’Haens et al. · Gastroenterology · 2008 · 494 citations · Full text

, , +9

Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease

Waqqas Afif, Edward V. Loftus, William A. Faubion et al. · The American Journal of Gastroenterology · 2010 · 486 citations · Full text

Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient

Niels Vande Casteele, Ann Gils, Sharat Singh et al. · The American Journal of Gastroenterology · 2013 · 342 citations